ImmunityBio
IBRX
IBRX
208 hedge funds and large institutions have $239M invested in ImmunityBio in 2025 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 74 increasing their positions, 41 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% less ownership
Funds ownership: 11.32% → 9.32% (-2%)
43% less call options, than puts
Call options by funds: $7.5M | Put options by funds: $13.2M
Holders
208
Holding in Top 10
–
Calls
$7.5M
Puts
$13.2M
Top Buyers
| 1 | +$9.08M | |
| 2 | +$7.01M | |
| 3 | +$2.55M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$2.34M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.35M |
Top Sellers
| 1 | -$7.68M | |
| 2 | -$6.63M | |
| 3 | -$6.35M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$3.13M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.71M |
